Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion

被引:30
|
作者
Ruiz-Torres, A [1 ]
Kirzner, MSD [1 ]
机构
[1] Univ Autonoma Madrid, Res Inst Gerontol & Metab, Madrid, Spain
关键词
ageing; parameters; longevity; insulin-like growth factor-1; testosterone; lean body mass;
D O I
10.1159/000065507
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. It is known that the growth process is related to an individual's life-span, but the role of growth hormone (GH) secretion in human ageing remains unknown. Objectives: This study has focussed on the influence of GH on ageing parameters and on its relationship with human longevity. Methods: To deal with the first issue, we compared ageing parameters of young (up to 39) and old (over 70) individuals having similar insulin-like growth factor-1 (IGF-1) blood levels. For the second one, the decline in IGF-1 levels was studied comparing its behaviour in the first half with that in the second half of adult life. The latter represents the period of life in which mortality progressively increases. Two hundred and five healthy individuals were chosen as subjects, well distributed by gender and age (between 19 and 93 years). Results: Old males with IGF-1 levels similar to young ones do not show the age-dependent decrease in serum testosterone and lean body mass, nor the increase in fat body mass. Other hormone-metabolic and nutritional parameters do not reveal any change compared with the results of all individuals. In females, the results do not allow to assume any IGF-1 influence. The behaviour of the linear regression in the second half of adult life of males, which becomes flat because old men having low IGF-1 blood levels die earlier, is consistent with these results. This effect, which is supported by predictive analysis, is not observed in females, i.e. the IGF-1 level declines in the second half of the women's adult life are only a little flatter than in the first half. Finally, extrapolating the regressions obtained in the first half of adulthood, the age at which the curve crosses the x-axis is 110 years for males and 132 for females. Conclusion: The presented study of IGF-1 levels suggests that the GH secretion in adulthood plays a determinant role not only for some regressive manifestations, but also for life potential. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 50 条
  • [21] Decrease in Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-1 Ratio in the First Week of Stroke Is Related to Positive Outcomes
    Mattlage, Anna E.
    Rippee, Michael A.
    Sandt, Janice
    Billinger, Sandra A.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (07): : 1800 - 1806
  • [22] Insulin-like growth factor-1 is a negative modulator of glucagon secretion
    Mancuso, Elettra
    Mannino, Gaia C.
    Di Fatta, Concetta
    Fuoco, Anastasia
    Spiga, Rosangela
    Andreozzi, Francesco
    Sesti, Giorgio
    [J]. ONCOTARGET, 2017, 8 (31) : 51719 - 51732
  • [23] Growth hormone and insulin-like growth factor-1: effects on the growth of glioma cell lines
    Friend, KE
    Khandwala, HM
    Flyvbjerg, A
    Hill, H
    Li, J
    McCutcheon, IE
    [J]. GROWTH HORMONE & IGF RESEARCH, 2001, 11 (02) : 84 - 91
  • [24] Growth hormone, insulin-like growth factor-1 and the cortisol-cortisone shuttle
    Stewart, PM
    Toogood, AA
    Tomlinson, JW
    [J]. HORMONE RESEARCH, 2001, 56 : 1 - 6
  • [25] Obesity, body composition and Growth Hormone/Insulin-like Growth Factor-1 axis
    Savastano, Silvia
    Di Somma, Carolina
    Pizza, Genoveffa
    Colao, Annamaria
    [J]. OBESITY AND METABOLISM-MILAN, 2009, 5 (01): : 42 - 49
  • [26] Growth hormone and insulin-like growth factor-1 in patients with acute myocardial infarction
    Friberg, L
    Werner, S
    Eggertsen, G
    Ahnve, S
    [J]. CIRCULATION, 1998, 98 (17) : 768 - 768
  • [27] Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: Friends or foes?
    Orskov, H
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1996, 45 (08): : 91 - 95
  • [28] Growth hormone and insulin-like growth factor-1 in the clinical management of burned patients
    Gilpin, DA
    Rutan, RL
    Herndon, DN
    [J]. IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS - MECHANISMS AND THERAPEUTIC APPROACHES, VOL II, PTS 1 AND 2, 1996, : 956 - 962
  • [29] No evidence for involvement of the growth hormone/insulin-like growth factor-1 axis in psoriasis
    Bjorntorp, E
    Wickelgren, R
    Bjarnason, R
    Swanbeck, G
    Carlsson, LMS
    Lindahl, A
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (05) : 661 - 665
  • [30] Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes
    Brown-Borg, HM
    Rakoczy, SG
    Romanick, MA
    Kennedy, MA
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 227 (02) : 94 - 104